News Column

Leading Small-Cap Stars Health Care Stock for August 29 Morning Session is Chromadex Corp (CDXC)

August 29, 2014

Equities Staff



The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps you find those companies with a strong foundation that are best positioned to capitalize on future success.

Here are today's top-performing health care Small-Cap Stars as of noon on the east coast:

Chromadex Corp (CDXC)



Chromadex Corp gained 7.89% to $1.18 in morning trading today. Volume reached 96,715 by noon. The stock's average daily volume is 86,527 shares. Chromadex Corp has a 52-week high of $2.15 and a 52-week low of $0.71, and its 50-day SMA and 200-day SMA are $1.31 and $1.48 respectively.

ChromaDex Corp through its subsidiaries, supplies phytochemical referance standards to research an array of potential attributes & reference materials, related contract services, technical consulting & proprietary ingredients.

Galectin Therapeutics Inc. (GALT)



Galectin Therapeutics Inc. gained 7% to $6.42 in morning trading today. Volume reached 523,879 by noon. The stock's average daily volume is 1,191,952 shares. Galectin Therapeutics Inc. has a 52-week high of $19.11 and a 52-week low of $4.28, and its 50-day SMA and 200-day SMA are $9.81 and $11.52 respectively.

Galectin Therapeutics, Inc. is a development-stage company engaged in drug research and development to create new therapies for fibrotic disease and cancer.

Provectus Biopharmaceuticals Inc. (PVCT)



Provectus Biopharmaceuticals Inc. gained 5.58% to $1.04 in morning trading today. Volume reached 244,042 by noon. The stock's average daily volume is 555,017 shares. Provectus Biopharmaceuticals Inc. has a 52-week high of $6.03 and a 52-week low of $0.30, and its 50-day SMA and 200-day SMA are $0.93 and $1.66 respectively.

Provectus Biopharmaceuticals Inc is a development-stage pharmaceutical company. It develops, licenses, and sells pharmaceutical products for oncology and dermatology indications.

Navidea Biopharmaceuticals (NAVB)



Navidea Biopharmaceuticals gained 4.77% to $1.34 in morning trading today. Volume reached 369,200 by noon. The stock's average daily volume is 500,697 shares. Navidea Biopharmaceuticals has a 52-week high of $3.01 and a 52-week low of $1.11, and its 50-day SMA and 200-day SMA are $1.35 and $1.67 respectively.

Navidea Biopharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of precision diagnostics and radiopharmaceutical agent.

Zogenix Inc. (ZGNX)



Zogenix Inc. gained 4.7% to $1.34 in morning trading today. Volume reached 1,354,760 by noon. The stock's average daily volume is 1,838,364 shares. Zogenix Inc. has a 52-week high of $5.19 and a 52-week low of $1.18, and its 50-day SMA and 200-day SMA are $1.59 and $2.80 respectively.

Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio



There's no crystal ball that will tell you what the outcome of this or that clinical trial is going to be. Even if there were, the one astonishingly wealthy person who owns it probably wouldn't share. But that doesn't mean that investing in the right small-cap health care companies can't pay dividends in the long term. While the future of a company's lead therapy may not be certain, most of its present fundamentals are. And while investing in the small-cap biotech market will always be hit-or-miss, investing in solidly built players should help boost that batting average.

Our Small-Cap Stars system uses a complex statistical regression to isolate those fundamental factors that previous success stories had in common and then identifies those small caps that are the most similar to that profile in the present.

For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most indicative of a small-cap company's potential for success.

All data provided by QuoteMedia and was accurate as of 12:00 pm ET.


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Equities.com


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters